Akram Khan MD

Pulmonology•Portland, OR

Critical Care Medicine, Pulmonary Vascular Medicine, Sleep Medicine

Associate Professor, Medicine, Oregon Health & Science University School of Medicine

Join to View Full Profile

3181 SW Sam Jackson Park RdUHN-67Portland, OR 97239
Phone+1 503-494-1620
Fax+1 503-494-6670

Summary

www.prismtrials.com

Education & Training

Oregon Health & Science UniversityMasters in Clinical Research, Clinical research, 2009 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Sleep Medicine, 2006 - 2007
University of Oklahoma Health Sciences CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2006
SSM Health/Saint Louis University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2001
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 1997 - 2000
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Surgery, 1995 - 1997
Maulana Azad Medical CollegeClass of 1994

Certifications & Licensure

WA State Medical License 2019 - 2026
OR State Medical License 2008 - 2025
FL State Medical License 2007 - 2009
IL State Medical License 2001 - 2008
MN State Medical License 2006 - 2008
OK State Medical License 2002 - 2007
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Sleep Quality and Presence of Sleep Disordered Breathing Start of enrollment: 2008 Jun 01
Completed
Predicting Hypotension During Dialysis in the ICU Start of enrollment: 2010 Jul 19
Withdrawn
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Start of enrollment: 2016 Feb 01
Withdrawn
Phase 2
Severe ARDS: Generating Evidence Start of enrollment: 2016 Oct 01
Completed
Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 Start of enrollment: 2020 Jun 01
Completed
Phase 2
A Study of Baricitinib (LY3009104) in Participants With COVID-19 Start of enrollment: 2020 Jun 12
Completed
Phase 3
GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection Start of enrollment: 2021 Mar 15
Recruiting
Not Applicable
Ventilation Imbalances in Mild to Moderate Chronic Obstructive Pulmonary Disease Start of enrollment: 2021 Jun 30
Enrolling by invitation
Nutrition and Exercise in Critical Illness Start of enrollment: 2017 Sep 28
Recruiting
Phase 2
Roles: Contact
Study of Treatment's Echocardiographic Mechanisms Start of enrollment: 2019 Apr 30
Unknown status
Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
COMPLETED
PHASE2, PHASE3
Roles: Contact
ADAPT - a Patient Registry of the Real-world Use of Orenitram® Start of enrollment: 2017 Jul 18
ACTIVE_NOT_RECRUITING
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome Start of enrollment: 2019 Nov 26
COMPLETED
PHASE2
Pragmatic Trial Examining Oxygenation Prior to Intubation Start of enrollment: 2022 Mar 10
COMPLETED
NA
Roles: Contact
Trial of Therapeutic Hypothermia in Patients With ARDS Start of enrollment: 2021 Jun 29
RECRUITING
PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.
Diya Surie, Katharine A Yuengling, Basmah Safdar, Adit A Ginde, Ithan D Peltan
JAMA Network Open. 2025-04-01
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
Akram Khan, Yuwei Zhu, Hilary M Babcock, Laurence W Busse, Abhijit Duggal
Vaccine. 2025-02-27
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, Caitlin C Ten Lohuis, Nathan D Nielsen
Journal of Critical Care. 2025-02-01

Press Mentions

Flu Deaths Rise as Anti-Vaccine Disinformation Takes RootMarch 18th, 2025
Late-Stage Neuromuscular Disorders: MAiDMay 23rd, 2023
Guidelines Developed for Respiratory Management of Neuromuscular DiseaseMarch 17th, 2023
Join now to see all